Clinical trials: Multinodular Goiter
Cholecystitis, Cholecystitis, Chronic
Shortwave Infrared Surgical Imaging Device Study
The goal of this observational study is to perform an in-human assessment of an investigational shortwave infrared (SWIR) imaging device, aimed to enhance the visualization of critical anatomical structures during surgical…
- Conditions
- Cholecystitis, Cholecystitis, Chronic, Chronic Calculous Cholecystitis, Primary Hyperparathyroidism
- Trial name
- NCT07744425
- Testing
- Observational study of SWIR imaging device in surgery
- Where
- 6 sites in United States
- Volunteers
- 50 people
- Sponsor
- Cision Vision, Inc.
Healthy
Study Comparing Thyrogen Versus a Modified Release of Recombinant Human Thyroid Stimulating Hormone
Forty-six (46) eligible, healthy subjects who provide written informed consent will be enrolled to participate in a 2 arm parallel group study to assess and compare the pharmacokinetics and safety profile of Thyrogen dosed at 0.1…
- Trial name
- NCT00137891
- Testing
- Modified Release rhTSH
- Where
- United States
- Volunteers
- 46 people, healthy volunteers welcome
- Sponsor
- Genzyme, a Sanofi Company
Benign Thyroid Disease
Harmonic FOCUS Versus Conventional Technique in Total Thyroidectomy for Benign Thyroid Disease
New haemostatic techniques have been developed with the advent of laparoscopic surgery. Among other things, ultrasound instruments have been used for the dissection, division and coagulation of vessels and other tissue.
- Trial name
- NCT00666315
- Where
- 2 sites in Belgium, Italy
- Volunteers
- 80 people
- Sponsor
- Ethicon Endo-Surgery (Europe) GmbH
Multinodular Goiter
Study to Determine the Dose, the Safety and Effectiveness of a New Drug, Modified Release rhTSH, in Patients With Multinodular Goiter
The purpose of this study is to determine the safety and effectiveness of 2 different doses of modified-release recombinant human thyroid stimulating hormone (MRrhTSH) when administered with radioiodine in patients with…
- Trial name
- NCT00454220
- Testing
- MRrhTSH
- Where
- 11 sites in United States, Brazil and 6 more
- Volunteers
- 96 people
- Sponsor
- Genzyme, a Sanofi Company